Dr. Chengjie Xiong Unveils Breakthrough PSRS Tool for RBD Trials

Dr. Chengjie Xiong, leader of the NAPS Data & Statistical Management Core

Dr. Chengjie Xiong, leader of the NAPS Data & Statistical Management Core, shared groundbreaking findings at the International Parkinson and Movement Disorder Society Congress.

NAPS has developed the Prodromal Synucleinopathy Rating Scale (PSRS) – a new outcome measure for neuroprotective clinical trials in RBD.

Using data-driven models built from NAPS participants, the PSRS can make future trials smaller, faster, and more feasible, paving the way for the next generation of synucleinopathy research.

🌐 We look forward to sharing more about the PSRS on our website soon – stay tuned!